[HTML][HTML] Compliance and patching and atropine amblyopia treatments

J Wang - Vision research, 2015 - Elsevier
In the past 20 years, there has been a great advancement in knowledge pertaining to
compliance with amblyopia treatments. The occlusion dose monitor introduced quantitative …

Recent advances in screening and treatment for amblyopia

EE Birch, KR Kelly, J Wang - Ophthalmology and Therapy, 2021 - Springer
Amblyopia is the most common cause of monocular visual impairment in children, with a
prevalence of 2–3%. Not only is visual acuity reduced in one eye but binocular vision is …

Compliance and predictors of spectacle wear in schoolchildren and reasons for non-wear: a review of the literature

P Morjaria, I McCormick, C Gilbert - Ophthalmic epidemiology, 2019 - Taylor & Francis
Purpose: Uncorrected refractive errors are the leading cause of visual impairment in
children, affecting children in all settings. The majority of refractive errors can be corrected …

Treatment compliance in amblyopia: A mini-review and description of a novel online platform for compliance tracking

T Le, F Örge - Survey of Ophthalmology, 2022 - Elsevier
Patient compliance with amblyopia therapies, including eye patching and atropine drops, is
crucial for optimal visual acuity outcomes. Studies utilizing objective measures of …

Feasibility of monitoring compliance with intermittent occlusion therapy glasses for amblyopia treatment

J Wang, J Jin, A Malik, R Shoge, S Meiyeppen… - Journal of American …, 2019 - Elsevier
Background Liquid crystal glasses use an intermittent occlusion technique and may improve
compliance compared to adhesive patches. Previous studies support the effectiveness of …

[HTML][HTML] Interventions for improving adherence to amblyopia treatments in children

J Mallios, D Chen, J Wang, S Han… - The Cochrane …, 2023 - ncbi.nlm.nih.gov
Interventions for improving adherence to amblyopia treatments in children - PMC Back to Top
Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main …

Limitations of the TheraMon®‐microsensor in monitoring occlusion therapy

C Schramm, A Abaza, G Blumenstock… - Acta …, 2016 - Wiley Online Library
Purpose A proof of principle study showed that the TheraMon®‐microsensor can reliably
measure wearing times of glasses and occlusion patches while having no discomfort for the …

Smart Devices in Optometry: Current and Future Perspectives to Clinical Optometry

D Ramamurthy, S Srinivasan, S Chamarty… - Clinical …, 2024 - Taylor & Francis
There is a huge unmet need for eye care with more than a hundred million people living
without basic eye care services and facilities. There is an exigency to deploy adequate …

Electronically monitored occlusion therapy in amblyopia with eccentric fixation

B Mehmed, M Fronius, T Pohl, H Ackermann… - Graefe's archive for …, 2022 - Springer
Purpose Amblyopia with eccentric fixation, especially when not diagnosed early, is a
therapeutic challenge, as visual outcome is known to be poorer than in amblyopia with …

[HTML][HTML] Assessment of adherence to visual correction and occlusion therapy in the Infant Aphakia Treatment Study

C Drews-Botsch, G Cotsonis, M Celano… - Contemporary clinical …, 2016 - Elsevier
Occlusion therapy throughout early childhood is believed to be efficacious in treating
deprivation amblyopia but has not been rigorously assessed in clinical trials. Further, tools to …